Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Nephrology|October 7, 2015
DNA double-strand breaks induced intractable glomerular fibrosis in renal allograftsYuki Matsui, Yumi Sunatani, Norifumi Hayashi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2012
Overexpression of TNF-α-converting enzyme in fibroblasts augments dermal fibrosis after inflammationShinji Fukaya, Yuki Matsui, Utano Tomaru, et al.
Auris, Nasus, Larynx|October 12, 2024
Sarcopenia as a predictive factor for febrile neutropenia during induction chemotherapy in head and neck squamous cell cancerKen Kasahara, Seiji Shigetomi, Yoichiro Sato, et al.
Surgical Case Reports|July 30, 2024
Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based chemotherapy followed by olaparibTakumi Funo, Daisuke Hashimoto, So Yamaki, et al.
Surgical Case Reports|June 15, 2026
Solid Pseudopapillary Neoplasm of the Pancreas Showing Spontaneous Regression Followed by Regrowth: A Case ReportYuji Ikeda, Daisuke Hashimoto, So Yamaki, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|June 25, 2026
Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant TherapyHidetaka Miyazaki, Mitsuaki Ishida, So Yamaki, et al.
Molecules (Basel, Switzerland)|January 8, 2009
The inhibitory action of kohamaic acid A derivatives on mammalian DNA polymerase betaYoshiyuki Mizushina, Daisuke Manita, Toshifumi Takeuchi, et al.
Cellular and Molecular Life Sciences : CMLS|May 10, 2022
IL4 stimulated macrophages promote axon regeneration after peripheral nerve injury by secreting uPA to stimulate uPAR upregulated in injured axonsYuki Matsui, Ken Kadoya, Yusuke Nagano, et al.
Cancer Letters|April 21, 2009
Structure and activity relationship of monogalactosyl diacylglycerols, which selectively inhibited in vitro mammalian replicative DNA polymerase activity and human cancer cell growthYuki Matsui, Takahiko Hada, Naoki Maeda, et al.
Neuropsychiatric Disease and Treatment|October 16, 2018
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trialsTaro Kishi, Kazuto Oya, Yuki Matsui, et al.
Pageof 12